Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt
Phase 4
Completed
- Conditions
- Polyneuropathy, Diabetic
- Interventions
- Drug: PlaceboDrug: Alpha-Lipoic Acid (ALA)
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Eva Pharma
- Target Recruit Count
- 430
- Registration Number
- NCT05813496
- Locations
- 🇪🇬
Alexandria University, Alexandria, Bab Sharqi, Egypt
🇪🇬Beni Suef University Hospital, Banī Suwayf, Beni-Suef, Egypt
🇪🇬Ain-Shams University Hospital, Cairo, Heliopolis, Egypt
Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection
Phase 1
- Conditions
- COVID-19
- Interventions
- Drug: PlaceboDrug: EgyVax Vaccine Candidate
- First Posted Date
- 2022-02-01
- Last Posted Date
- 2022-02-23
- Lead Sponsor
- Eva Pharma
- Target Recruit Count
- 45
- Registration Number
- NCT05218070
- Locations
- 🇪🇬
Cairo University Hospitals (Al-Manial Specialized University Hospital), Cairo, Egypt
Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis
Completed
- Conditions
- Active Rheumatoid Arthritis
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2020-06-30
- Lead Sponsor
- Eva Pharma
- Target Recruit Count
- 398
- Registration Number
- NCT03599986
- Locations
- 🇪🇬
Private clinics, Cairo, Egypt
© Copyright 2025. All Rights Reserved by MedPath